Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Planning update |
| Buyer: | Imperial College Healthcare NHS Trust |
| Main Category: | Services |
| Procurement Method: | — |
| Tender Status: |
| Pre-tender |
| Estimated Value (ex. VAT): | £3,000,000 |
| Estimated Value (inc. VAT): | £3,600,000 |
| Release Date: | 3 June 2026 |
| Application Deadline: | 3 July 2026 |
| Procurement ID (OCID): | ocds-h6vhtk-06ac2e |
| Notice Reference: | 052248-2026 |
All 2 notices for this procurement, oldest first.
Pre Market Engagement - NGS HLA Typing Systems and Reagents (NWLP H&I Services)
Pre Market Engagement - NGS HLA Typing Systems and Reagents (NWLP H&I Services)
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
Inclusion of Atamis web link and Contract Reference number
Pre-Market Engagement Notice – Next Generation Sequencing (NGS) HLA Typing Systems and Reagents North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, is undertaking pre‑market engagement to gauge market interest and capability ahead of potential future commissioning and procurement activity. This notice is issued for market testing purposes only and does not constitute a commitment to procure, nor does it form part of any formal procurement process. Feedback received will be used to inform commissioning intent, procurement strategy and the development of a future service specification in line with NHS procurement principles of transparency, proportionality, equal treatment and value for money. Background and Context NWLP provides Histocompatibility & Immunogenetics (H&I) services supporting renal transplantation, allogeneic stem cell transplantation and other solid organ transplant programmes across North West London and beyond. High‑resolution HLA typing using Next Generation Sequencing (NGS) is a mandatory clinical requirement and represents the current national and international standard of care. Demand for NGS HLA typing has grown significantly over recent years, driven by expanding transplant programmes and increasing clinical complexity. Current annual reagent expenditure is approximately £600k–£700k, with a projected contract value of £3–3.5m over an expected five‑year term. NWLP is therefore exploring future procurement options to ensure a sustainable, compliant and value‑for‑money solution that supports service resilience, innovation and clinical quality. Suppliers who are interested in this opportunity should complete the attached questionnaire and respond back by July 3rd 2026. To access the opportunity, please use Atamis via contract reference 'C451253'. https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001e3fTKIAY&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com
Published contracts in the last 12 months
39
total contracts
£1760.1m
total value
£135,391,565
average contract size
Typical categories
Pre Market Engagement - NGS HLA Typing Systems and Reagents (NWLP H&I Services)
Imperial College Healthcare NHS Trust · WAC-606629
Managed Equipment Services
Imperial College Healthcare NHS Trust · WAC-605963
ICS Courier Service Procurement
Imperial College Healthcare NHS Trust · WAC-596034
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
3 July 2026
29 days left
Estimated Value
£3,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →